Diagnostic and relapse diffuse large B-cell lymphoma (DLBCL) biopsies reveal increased mutational burden/loss of heterozygosity in . Serially sampled tumor biopsies provide insight into therapeutic targets and evolutionary divergence in relapsed/refractory DLBCL.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7218413 | PMC |
http://dx.doi.org/10.1182/bloodadvances.2019001325 | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!